Results of Treatment with Rituximab (Anti-CD20) in Three Patients with Autoimmune Hemolytic Anemia and/or Immune Thrombocytopenia and a Concise Review of Reported Cases

Publisher： Karger

E-ISSN： 1660-3818|29|5|277-281

ISSN： 1660-3796

Source： Transfusion Medicine and Hemotherapy, Vol.29, Iss.5, 2002-10, pp. : 277-281

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment of CNS Lymphoma with the Anti-CD20 Antibody Rituximab: Experience with Two Cases and Review of the Literature

By  

Oncology Research and Treatment, Vol. 26, Iss. 4, 2003-09 ,pp. : 351-354

Karger

Access to resources Recommend Favorite

Acute autoimmune hemolytic anemia due to anti‐Ena autoantibody successfully treated with rituximab

By  

TRANSFUSION, Vol. 58, Iss. 1, 2018-01 ,pp. : 176-180

John Wiley & Sons Inc

Access to resources Recommend Favorite

Treatment Options for Primary Autoimmune Hemolytic Anemia: A Short Comprehensive Review

By  

Transfusion Medicine and Hemotherapy, Vol. 42, Iss. 5, 2015-08 ,pp. : 294-301

Karger

Access to resources Recommend Favorite

Autoimmune hemolytic anemia as a paraneoplastic phenomenon in solid tumors: A critical analysis of 52 cases reported in the literature

By Puthenparambil Joe  

Wiener klinische Wochenschrift, Vol. 122, Iss. 7-8, 2010-04 ,pp. : 229-236

Springer Publishing Company

Access to resources Recommend Favorite

Effective Treatment of Refractory Pulmonary Hemorrhage with Monoclonal Anti-CD20 Antibody (Rituximab)

By  

Respiration, Vol. 78, Iss. 1, 2008-09 ,pp. : 106-109

Karger

Access to resources Recommend Favorite